SMMT Live signals | Maximize Profits with Getagraph.com

BUY 123353 min ago

@ $4.41

Issued: 14 Feb 2024 @ 15:08

Return: 8.39%

Previous signal: Feb 14 - 14:15

Previous signal: Sell

Return: -0.23 %

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 16:00):

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America...

Stats
Today's Volume	2.08M
Average Volume	2.28M
Market Cap	3.36B
EPS	$0 ( 2024-05-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	12.58
ATR14	$0.0110 (0.23%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-11	Ronaghi Mostafa	Buy	25 315	Stock Option (right to buy)
2024-04-11	Ronaghi Mostafa	Buy	200 000	Stock Option (right to buy)
2024-04-11	Ronaghi Mostafa	Buy	0
2024-04-02	Soni Manmeet Singh	Buy	1 100 000	Stock Option (right to buy)
2024-04-02	Anand Bhaskar	Buy	600 000	Stock Option (right to buy)

INSIDER POWER
99.42
Last 89 transactions
Buy: 581 405 260 \| Sell: 937 995

Volume Correlation

Long: -0.41 (neutral)

Short: -0.89 (strong negative)

Signal:(41.982) Neutral

Summit Therapeutics plc Correlation

10 Most Positive Correlations
ACST	0.898
TATT	0.892
NPCE	0.892
DRTT	0.89
VSTM	0.884
AVIR	0.881
GLMD	0.881
MREO	0.879
CNXC	0.872
SRPT	0.87

10 Most Negative Correlations
MTEK	-0.922
BFRI	-0.905
CINC	-0.873
SNCR	-0.868
MLVF	-0.862
SLDP	-0.858
LEDS	-0.858
PPBT	-0.858
XPDI	-0.856
PMD	-0.852

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Summit Therapeutics plc Correlation - Currency/Commodity

0.35
( neutral )

0.27
( neutral )

0.00
( neutral )

-0.38
( neutral )

-0.77
( moderate negative )

-0.07
( neutral )

Summit Therapeutics plc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-2.05M (0.00 %)
EPS:	$-0.990

FY	2023
Revenue:	$0
Gross Profit:	$-2.05M (0.00 %)
EPS:	$-0.990

FY	2022
Revenue:	$704 295
Gross Profit:	$-1.81M (-256.95 %)
EPS:	$-0.380

FY	2021
Revenue:	$1 809.00
Gross Profit:	$1 809.00 (100.00 %)
EPS:	$-0.000960

Financial Reports:

No articles found.

Summit Therapeutics plc

Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.